Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-17

FDA Approved: DRAX EXAMETAZIME — Original Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)

View source ↗

Summary

FDA approved DRAX EXAMETAZIME as a kit for the preparation of technetium-99m exametazime used for labeling leukocytes in imaging to detect infection and inflamm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DRAX EXAMETAZIME (kit for the preparation of technetium-99m exametazime for leukocyte labeling)

Snippet

ORIG AP for DRAX EXAMETAZIME (KIT FOR THE PREPARATION OF TECHNETIUM TC 99M EXAMETAZIME FOR LEUKOCYTE LABELING)